Notably, the median CSF/serum ratio of albumin (QAlb), which is a marker of blood-CSF barrier integrity [31], was within normal ranges in these groups and showed no significant differences between patients with IIH and MS. This evidence concerns the gene ALB and myeloid sarcoma.